Current and historical daily PE Ratio for CSPC Pharmaceutical Group Ltd (
) from 1990 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CSPC Pharmaceutical Group stock (FRA:CVG) PE ratio as of Jun 19 2024 is 12.28.
More Details
CSPC Pharmaceutical Group Ltd (FRA:CVG) PE Ratio (TTM) Chart
CSPC Pharmaceutical Group Ltd (FRA:CVG) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1289
- 1
- 2
- 3
- 4
- 5
- 6
- 15
CSPC Pharmaceutical Group PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-19 | 11.7 | 2024-04-16 | 10.5 |
2024-06-18 | 11.7 | 2024-04-15 | 10.5 |
2024-06-17 | 12.0 | 2024-04-12 | 10.7 |
2024-06-14 | 12.2 | 2024-04-11 | 11.0 |
2024-06-13 | 12.2 | 2024-04-10 | 10.9 |
2024-06-12 | 12.1 | 2024-04-09 | 11.0 |
2024-06-11 | 12.2 | 2024-04-08 | 11.0 |
2024-06-10 | 12.6 | 2024-04-05 | 10.9 |
2024-06-07 | 12.4 | 2024-04-04 | 10.9 |
2024-06-06 | 12.2 | 2024-04-03 | 11.1 |
2024-06-05 | 12.2 | 2024-04-02 | 11.4 |
2024-06-04 | 12.3 | 2024-03-28 | 11.0 |
2024-06-03 | 12.5 | 2024-03-27 | 11.2 |
2024-05-31 | 12.0 | 2024-03-26 | 11.3 |
2024-05-30 | 12.2 | 2024-03-25 | 11.2 |
2024-05-29 | 12.1 | 2024-03-22 | 11.5 |
2024-05-28 | 12.5 | 2024-03-21 | 11.4 |
2024-05-27 | 11.9 | 2024-03-20 | 11.4 |
2024-05-24 | 11.4 | 2024-03-19 | 11.3 |
2024-05-23 | 11.5 | 2024-03-18 | 11.6 |
2024-05-22 | 11.7 | 2024-03-15 | 11.8 |
2024-05-21 | 11.7 | 2024-03-14 | 11.5 |
2024-05-20 | 12.1 | 2024-03-13 | 11.3 |
2024-05-17 | 11.7 | 2024-03-12 | 11.2 |
2024-05-16 | 11.9 | 2024-03-11 | 10.5 |
2024-05-15 | 12.0 | 2024-03-08 | 10.4 |
2024-05-14 | 12.1 | 2024-03-07 | 10.3 |
2024-05-13 | 12.6 | 2024-03-06 | 10.4 |
2024-05-10 | 12.2 | 2024-03-05 | 10.6 |
2024-05-09 | 12.2 | 2024-03-04 | 10.6 |
2024-05-08 | 12.0 | 2024-03-01 | 10.8 |
2024-05-07 | 12.0 | 2024-02-29 | 10.8 |
2024-05-06 | 12.2 | 2024-02-28 | 11.1 |
2024-05-03 | 12.1 | 2024-02-27 | 11.2 |
2024-05-02 | 12.1 | 2024-02-26 | 11.5 |
2024-04-30 | 11.8 | 2024-02-23 | 11.2 |
2024-04-29 | 12.5 | 2024-02-22 | 11.1 |
2024-04-26 | 11.9 | 2024-02-21 | 11.2 |
2024-04-25 | 11.6 | 2024-02-20 | 10.9 |
2024-04-24 | 11.2 | 2024-02-19 | 10.9 |
2024-04-23 | 10.9 | 2024-02-16 | 11.0 |
2024-04-22 | 10.9 | 2024-02-15 | 10.7 |
2024-04-19 | 10.6 | 2024-02-14 | 10.7 |
2024-04-18 | 10.6 | 2024-02-13 | 11.0 |
2024-04-17 | 10.5 | 2024-02-12 | 10.4 |
CSPC Pharmaceutical Group Ltd (FRA:CVG) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
CSPC Pharmaceutical Group Ltd
ISIN : HK1093012172
Compare
Compare
Traded in other countries / regions
01093.Hong KongCVG.GermanyCSPCY.USA1093.Mexico Description
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.